Skip to Main Content

Staff Resources Speed FDA Drug Review: A Critical Analysis of the Returns to Resources in Approval Regulation

J Health Polit Policy Law (2004) 29 (3): 431-442.
Currently there are no citedby results. Try again later.
Close Modal
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close Modal
Close Modal